AstraZeneca price target lowered to 165 GBp from 172 GBp at HSBC
HSBC lowered the firm's price target on AstraZeneca to 165 GBp from 172 GBp and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "a